Haldol side effects

The use of the Truven Health Analytics products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Truven Health Analytics makes no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, TRUVEN HEALTH ANALYTICS MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE TRUVEN HEALTH ANALYTICS PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Truven Health Analytics does not assume any responsibility or risk for your use of the Truven Health Analytics products.

Haldol is available in sterile vials containing 5 mg strength Haldol per 1 ml of fluid used for injection. Usual starting dose is -5 mg intramuscularly. Dose may vary according to patient response to the drug. Switch to an oral form of this drug is recommended as soon as possible. Haldol may interact with other drugs so the patient needs close observation or monitoring to determine if other side effects develop. Haldol should only be used during pregnancy or in women likely to become pregnant only if the benefit clearly justifies a potential risk to the fetus; fetal abnormalities and fetal exposure to Haldol in the third trimester have shown dependence at birth. Women who are breastfeeding should not take Haldol because the drug may affect the infant. Although reports of use for behavior modification exist, the drug is not approved for use in children.

The intravenous route is not FDA approved and is generally not recommended except when no other alternatives are available. Intravenous administration appears to be associated with a higher risk of QT prolongation and torsade de pointes (TdP) than other forms of administration. The manufacturer recommends ECG monitoring for QT prolongation and arrhythmias if IV administration is required. A dose in the range of 1 to 5 mg IV has been suggested, with the dose being repeated at 30 to 60 minute intervals, if needed. A maximum IV dose has not been established. The lowest effective dose should be used in conjunction with conversion to oral therapy as soon as possible.

The following adverse reactions have been identified during postapproval use of risperidone. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. These adverse reactions include: alopecia , anaphylactic reaction, angioedema , atrial fibrillation , cardiopulmonary arrest, diabetic ketoacidosis in patients with impaired glucose metabolism , dysgeusia, hypoglycemia , hypothermia , ileus , inappropriate antidiuretic hormone secretion, intestinal obstruction, jaundice , mania, pancreatitis , pituitary adenoma , precocious puberty, pulmonary embolism , QT prolongation, sleep apnea syndrome, sudden death, thrombocytopenia , thrombotic thrombocytopenic purpura , urinary retention, and water intoxication .

Haldol side effects

haldol side effects

The following adverse reactions have been identified during postapproval use of risperidone. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. These adverse reactions include: alopecia , anaphylactic reaction, angioedema , atrial fibrillation , cardiopulmonary arrest, diabetic ketoacidosis in patients with impaired glucose metabolism , dysgeusia, hypoglycemia , hypothermia , ileus , inappropriate antidiuretic hormone secretion, intestinal obstruction, jaundice , mania, pancreatitis , pituitary adenoma , precocious puberty, pulmonary embolism , QT prolongation, sleep apnea syndrome, sudden death, thrombocytopenia , thrombotic thrombocytopenic purpura , urinary retention, and water intoxication .

Media:

haldol side effectshaldol side effectshaldol side effectshaldol side effectshaldol side effects

http://buy-steroids.org